U.S. Patents Awarded to Inventors in Massachusetts (Sept. 28)
| Targeted News Service |
***
ChemGenes Assigned Patent
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides building blocks and methods for synthesizing very pure RNA in a form that can efficiently be modified at the 3' end. Reverse RNA monomer phosphoramidites have been developed for RNA synthesis in 5'.fwdarw.3' direction, leading to very clean oligo synthesis that allows for the introduction of various modifications at the 3'-end cleanly and efficiently. Higher coupling efficiency per step have been observed during automated oligo synthesis with the reverse RNA amidites disclosed herein, resulting in a greater ability to achieve higher purity and produce very long oligonucleotides. The use of the reverse RNA phosphoramidites in the synthetic process of this invention leads to oligonucleotides free of N+1 species."
The patent application was filed on
Written by
***
Isis Pharmaceuticals Assigned Patent
The abstract of the patent published by the U.S. Patent and Trademark Office states: "Universal linkers, their facile processes of manufacture and methods of using the same are provided."
The patent application was filed on
Written by
***
Infinity Pharmaceuticals Assigned Patent
The abstract of the patent published by the U.S. Patent and Trademark Office states: "Provided herein are compounds of formula (I): or pharmaceutically acceptable salts, solvates or prodrugs thereof or mixtures thereof, wherein Z.sup.1, Z.sup.2, X.sup.1, X.sup.2, X.sup.3, R.sup.1, R.sup.2, R.sup.3, R.sup.4, m and n are defined herein. Also provided are pharmaceutically acceptable compositions that include a compound of formula I and a pharmaceutically acceptable excipient. Also provided are methods for treating an FAAH-mediated disorder comprising administering to a subject in need thereof a therapeutically effective amount of a compound or composition of the present invention. ##STR00001##."
The patent application was filed on
Written by
***
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to methods for the labeling of nucleic acid polymers in vitro and in vivo. Certain methods are provided that include a [3+2] cycloaddition between a nucleotide analogue incorporated into a nucleic acid polymer and a reagent attached to a label. Other methods are provided that include a Staudinger ligation between a nucleotide analogue incorporated into a nucleic acid polymer and a reagent comprising a substituted triarylphosphine attached to a label. Such methods do not require fixation and denaturation and therefore can be applied to the labeling of nucleic acid polymers in living cells and in organisms. Also provided are methods for measuring cellular proliferation. In these methods, the amount of label incorporated into the DNA is measured as an indication of cellular proliferation. The methods of the invention can be used in a wide variety of applications including clinical diagnosis of diseases and disorders in which cellular proliferation is involved, toxicity assays, and as a tool for the study of chromosomes' ultrastructures."
The patent application was filed on
Written by
***
General Hospital Assigned Patent
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention provides fabricated PVA-hydrogels, PVA-hydrogel-containing compositions, and methods of making the same. The invention also provides methods of implanting or administering the PVA-hydrogels, or the PVA-hydrogel-containing compositions to treat a subject in need. Methods of cross-linking pre-solidified or pre-gelled hydrogel particles and making cross-linked PVA-hydrogels, and cross-linked PVA-hydrogel-containing compositions also are disclosed herein."
The patent application was filed on
Written by
***
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention is directed to imidazoisoindole compounds which are antagonists of neuropeptide S receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which the neuropeptide S receptor is involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the neuropeptide S receptor is involved."
The patent application was filed on
Written by
***
Lockheed Martin Assigned Patent
The abstract of the patent published by the U.S. Patent and Trademark Office states: "A system for enhancing control of an underwater vehicle, and providing a quick change modular payload section includes a motor configured to rotate an internally threaded member threadingly engaged with a threaded rod. Rotating the member creates linear motion of the threaded rod. A control rod connected to the threaded rod provides movement of a rudder or fin. The threaded rod and member are configured with threads having a fine pitch which maintains a stable position of the fins without needing to supply power to the motor for adjustments. The modular payload arrangement includes a bulkhead ring having L-shaped recesses that receive fasteners disposed on a central body section. The payload section may be fastened to the vehicle by pressing the payload section onto the central body such that the fasteners align with the recesses and turning the payload section to secure the payload section."
The patent application was filed on
Written by Satyaban Rath; edited by
***
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to cell wall degradative systems, in particular to systems containing enzymes that bind to and/or depolymerize cellulose. These systems have a number of applications."
The patent application was filed on
Written by
***
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to thiazolinones and also to pharmaceutical compositions comprising the compounds, as well as methods of use of the compounds for treatment of disorders associated with human 11-.beta.-hydroxysteroid dehydrogenase type 1 enzyme and for the preparation of a medicament which acts on the human 11-.beta.-hydroxysteroid dehydrogenase type 1 enzyme."
The patent application was filed on
Written by
***
Merck Sharp & Dohme Assigned Patent
The abstract of the patent published by the U.S. Patent and Trademark Office states: "This invention relates to compounds of the Formula (I): (Chemical formula should be inserted here as it appears on abstract in paper form) (I) or a pharmaceutically acceptable salt, solvate or isomer thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs,
The patent application was filed on
Written by
***
Waters Technologies Assigned Patent
The abstract of the patent published by the U.S. Patent and Trademark Office states: "A device comprising a pressure monitor and a control means that receives a signal representing measured pressure at the pressure monitor and controls the controllable elements of a fluid system is utilized to monitor a fluid system for error conditions, to optimize operations and to diagnose the fluid system. By following a testing protocol that selectively enables parts of the system, the control means narrows the list of possible failing components. Comparing the measured pressure against normal pressures allows the device to identify error conditions. Determining the volume of fluid being transported and controlling the duration of the flow optimizes operation of the fluid system."
The patent application was filed on
Written by Satyaban Rath; edited by
***
Foster-Miller Assigned Patent
The abstract of the patent published by the U.S. Patent and Trademark Office states: "A net deployment system which, in one example, includes lengthy housing with a channel therein, a net folded in the channel, a lengthy bladder fixed to the housing and in the channel behind the net, attachments between the net and the bladder, and at least one inflator charge for inflating the bladder to deploy the net out of the channel."
The patent application was filed on
Written by Satyaban Rath; edited by
***
International Business Machines Assigned Patent for Business Practices Alignment Methods
Written by
***
Casella Waste Systems Assigned Patent
The abstract of the patent published by the U.S. Patent and Trademark Office states: "Systems and methods for authorizing a waste item to be removed from a site. In one embodiment, a waste collection vehicle includes a reader configured to obtain identification information from an identification tag associated with the waste item. A transceiver associated with the vehicle is configured to: receive the identification information from the reader, wirelessly transmit the identification information to a remote computer for processing, and wirelessly receive an indication of whether the waste item should be collected and removed by the waste collection. The received indication is based on at least one hazardous characteristic associated with the identified waste item, a determination that the waste collection vehicle is authorized to collect the waste item having the at least one hazardous characteristic, and a determination that a driver of the waste collection vehicle is authorized to collect the waste item having the at least one hazardous characteristic."
The patent application was filed on
Written by
***
Bluefin Labs Assigned Patent
Written by
***
Fresenius Medical Care Holdings Assigned Patent
***
International Business Machines Assigned Patent for Methods, Systems, and Computer Program Products for Providing an Information Storage Management System
Written by
***
Intel Assigned Patent for Apparatus, System, and Method for Voltage Swing and Duty Cycle Adjustment
The abstract of the patent published by the U.S. Patent and Trademark Office states: "Described herein are an apparatus, system, and method for compensating voltage swing and duty cycle of a signal on an input-output (I/O) pad of a processor by adjusting the voltage swing and duty cycle of the signal. The apparatus comprises a driver to transmit a signal on an I/O pad, the signal on the I/O pad having a voltage swing and a duty cycle; and an adjustment unit, coupled to the driver, to receive the signal from the I/O pad transmitted by the driver and to generate voltage swing and duty cycle control signals for adjusting the voltage swing and duty cycle of the signal on the I/O pad respectively. Described herein is also an analog-to-digital (A2D) converter for measuring and/or calibrating various signal attributes including current, voltage, and time."
The patent application was filed on
Written by
***
Aurus Assigned Patent
Written by
***
STB Enterprises Assigned Patent
Written by
***
Google Assigned Patent for Competitive Availability Tools
Written by
***
***
Waters Technologies Assigned Patent
The abstract of the patent published by the U.S. Patent and Trademark Office states: "A flow through isolation valve having a stationary member; a movable member, with a surface of the stationary member interfacing with a surface of the movable member; and at least one pin isolation valve. The pin isolation valve has a flow through internal conduit and is movable so that the internal conduit can fluidically communicate with at least one blank opening in the movable member and with a flow through internal conduit in the movable member. Movement is by rotation, linear or curvilinear translation. At least one pin isolation valve is fluidically coupled typically to a sample loop of a face seal valve, or to a pump supplying high pressure liquid to or to a column discharging liquid from a face seal valve of a high pressure liquid chromatography (HPLC) system or directly to the face seal valve."
The patent application was filed on
Written by Satyaban Rath; edited by
***
Vertex Pharmaceuticals Assigned Patent
The abstract of the patent published by the U.S. Patent and Trademark Office states: "An immediate release formulation of an active ingredient."
The patent application was filed on
Written by Satyaban Rath; edited by
***
Cnano Technology Assigned Patent
The abstract of the patent published by the U.S. Patent and Trademark Office states: "
The patent application was filed on
Written by Satyaban Rath; edited by
***
Tesla Motors Assigned Patent
The abstract of the patent published by the U.S. Patent and Trademark Office states: "A port door unlatching system is provided that may be used to open the door covering the charge port of an electric vehicle, or the door covering the fuel filler port of a conventional vehicle. The system includes a fuel delivery subsystem with a fuel coupler (e.g., a charging connector or a gas nozzle) designed to transfer fuel from the source to the vehicle via the vehicle's fuel port. The fuel coupler includes a switch that when toggled, causes a control signal to be wirelessly transmitted over a short distance. Upon receipt of the control signal by a receiver integrated into a vehicle that is in close proximity to the fuel port, an unlatching actuator within the vehicle unlatches the port door, thereby allowing it to open and provide port access."
The patent application was filed on
Written by Satyaban Rath; edited by
***
***
Oracle International Assigned Patent
The abstract of the patent published by the U.S. Patent and Trademark Office states: "An aspect of the present invention simplifies generating a star schema from a snowflake schema. In an embodiment, a user first specifies fact tables to be included in a star schema, and a synchronization tool inspects the snowflake schema to determine the dimension tables linked to the specified fact tables. The determined dimension tables are included in the star schema sought to be generated."
The patent application was filed on
Written by Satyaban Rath; edited by
***
Schlumberger Technology Assigned Patent for Apparatus and Method for Treating a Subterranean Formation Using Diversion
The abstract of the patent published by the U.S. Patent and Trademark Office states: "Apparatus and method comprising a plurality of particles which are magnetically attracted to one another in response to exposure to a magnetic field, and which maintain attraction to one another after removal of the magnetic field, the attraction being disabled when the particles are demagnetized, whereby the particles operate to alter the rheological properties of a fluid in which the particles are mixed when the attraction is enabled or disabled is disclosed."
The patent application was filed on
Written by Satyaban Rath; edited by
***
Oracle International Assigned Patent
The abstract of the patent published by the U.S. Patent and Trademark Office states: "An RFID edge server is adapted to receive
The patent application was filed on
Written by
***
Agenus Assigned Patent
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to methods and compositions for the prevention and treatment of herpes virus infections. The invention provides antigenic peptides, and pharmaceutical compositions comprising complexes of antigenic peptides and adjuvants that can activate an immune response against herpes viruses. The invention also provides methods of making the antigenic peptides and complexes of antigenic peptides and adjuvants. Methods of use of the pharmaceutical compositions are also provided."
The patent application was filed on
Written by Satyaban Rath; edited by
***
Kraft Foods Group Brands Assigned Patent
The abstract of the patent published by the U.S. Patent and Trademark Office states: "A food package for segregating ingredients of a multi-component food product, such as the multiple components of a sandwich, the package comprising an outer container to house a first food component and at least one flexible envelope or barrier film layer that encloses at least one intermediate food component allowing for separation of the intermediate food component during extended periods of storage and prior to opening the product. A method for opening the package comprises applying a pulling force to an externally located protruding end portion of the envelope, such that the envelope peels apart and separates into ruptured layers that are pulled out of the food product and out of the outer container by the continual pulling force from the protruding end portion."
The patent application was filed on
Written by Satyaban Rath; edited by
***
Cognex Assigned Patent
The abstract of the patent published by the U.S. Patent and Trademark Office states: "This invention provides a system and method captures a moving image of a scene that can be more readily de-blurred as compared to images captured through the above-referenced and other known methods operating on an equivalent exposure-time interval. Rather than stopping and starting the integration of light measurement during the exposure-time interval, photo-generated current is switched between multiple charge storage sites in accordance with a temporal switching pattern that optimizes the conditioning of the solution to the inverse blur transform. By switching the image intensity signal between storage sites all of the light energy available during the exposure-time interval is transduced to electronic charge and captured to form a temporally decomposed representation of the moving image. As compared to related methods that discard approximately half of the image intensity signal available over an equivalent exposure-time interval, such a temporally decomposed image is a far more complete representation of the moving image and more effectively de-blurred using simple linear de-convolution techniques."
The patent application was filed on
Written by
***
Agere Systems Assigned Patent
The abstract of the patent published by the U.S. Patent and Trademark Office states: "Disclosed is a circuit for adjusting a voltage supplied to an IC by a power supply circuit that produces a regulated-output voltage based on an output-control signal generated by a resistive voltage divider. The circuit includes a PVT detector configured to generate an interface control signal and an interface circuit (i) connected to PVT detector and to the resistive voltage divider and (ii) configured to adjust its resistance in response to the interface control signal. Adjusting the resistance of the interface circuit causes the voltage of the output-control signal to be adjusted, thus causing the power supply circuit to adjust the regulated output voltage."
The patent application was filed on
Written by
***
Amgen Assigned Patent
The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to methods of making compounds that inhibit 11-hydroxysteroid dehydrogenase type 1 enzyme (11-HSD1). One method comprises (a) contacting a compound of formula (II) sequentially with a chiral base in the presence of an amine, and an alkylating agent R3-LG, (b) contacting the product of (a) with an acid to form a salt, and (c) reacting the salt with a base to form the compound of formula (I), wherein Z, R1, R2, and R3 are defined herein."
The patent application was filed on
Written by
For more information about
-1139704
| Copyright: | (c) 2013 Targeted News Service |
| Wordcount: | 6799 |



U.S. Patents Awarded to Inventors in Connecticut (Sept. 28)
U.S. Patents Awarded to Inventors in Texas (Sept. 28)
Advisor News
- House panel votes to raise certain taxes, transfer money to offset Medicaid shortfall
- Iowa House backs temporary tax hike to fill Medicaid gap
- Iowa Medicaid temporary tax plan draws sharp public opposition
- Charitable giving planning can strengthen advisor/client relationships
- New $6K deduction could provide tax planning window for retirees
More Advisor NewsAnnuity News
- We can help find a loved one’s life insurance policy
- 2025: A record-breaking year for annuity sales via banks and BDs
- Lincoln Financial launches two new FIAs
- Great-West Life & Annuity Insurance Company trademark request filed
- The forces shaping life and annuities in 2026
More Annuity NewsHealth/Employee Benefits News
- In U.S. Health Insurance Market, Consolidation Of Insurers Is Increasing Premiums
- Health insurance jargon can be frustrating and confusing – here's how to navigate it
- Minnesota Blue Cross CEO steps down from Sutter Health board over conflict of interest
- 'No-cost" Lantern surgical benefit has modest early use from SHP members
- House panel votes to raise certain taxes, transfer money to offset Medicaid shortfall
More Health/Employee Benefits NewsLife Insurance News
- Murray Giles Hulse
- New individual life premium hits record-setting $17.5B in 2025
- Maryland orders Cigna to halt underpaying doctors or give cause
- Insurers optimistic about their investments in 2026
- AM Best Affirms Credit Ratings of PVI Insurance Corporation
More Life Insurance News